NCT04018417View on ClinicalTrials.gov

Evaluation of Amphotericin B in Optisol-GS for Prevention of Post-Keratoplasty Fungal Infections.

PHASE2/PHASE3WithdrawnINTERVENTIONAL
0
Timeline

Start Date

July 3, 2019

Primary Completion Date

July 3, 2019

Study Completion Date

July 3, 2019

Conditions
Fuchs' Endothelial Dystrophy
Interventions
DRUG

Amphotericin B

Drug concentration: 0.255 μg/mL

Trial Locations (1)

46260

Price Vision Group, Indianapolis

Sponsors
All Listed Sponsors
lead

Cornea Research Foundation of America

OTHER